Sprague John M
Chief Financial Officer at T2 Biosystems, Inc.
- Sold, on record
- $16k
- Dollars the filings state
- Form 4 sales
- 3
- Latest Feb 28, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- T2 Biosystems, Inc.Chief Financial Officer
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale T2 Biosystems, Inc.Plan not statedFeb 24, 2020 2020
Sold 4,166 shares at $0.82 ($3k)
Sprague John M, Chief Financial Officer
Sold 15.8% of holdings ($22k position)22,222 shares leftFirst sale on recordFiling
- 2 Form 4 sale T2 Biosystems, Inc.Plan not statedFeb 23, 2021 +365 days
Sold 5,250 shares at $2.04 ($11k)
Sprague John M, Chief Financial Officer
Sold 12.9% of holdings ($83k position)35,485 shares leftFiling
- 3 Form 4 sale T2 Biosystems, Inc.UnusualFeb 28, 2023 +735 days
Sold 2,693 shares at $0.62 ($2k)
Sprague John M, Chief Financial Officer
Sold 27% of holdings ($6k position)7,268 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (3)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2023 | Mar 9, 2023 | T2 Biosystems, Inc. | Chief Financial Officer | Form 4 sale | 2,693 | $2k | 27.0% | Unusual | SEC |
| Feb 23, 2021 | Feb 23, 2021 | T2 Biosystems, Inc. | Chief Financial Officer | Form 4 sale | 5,250 | $11k | 12.9% | Plan not stated | SEC |
| Feb 24, 2020 | Mar 3, 2020 | T2 Biosystems, Inc. | Chief Financial Officer | Form 4 sale | 4,166 | $3k | 15.8% | Plan not stated | SEC |